GF
EW icon

Gerstein Fisher’s Edwards Lifesciences EW Stock Holding History

Gerstein Fisher’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$286K Sell
7,107
-69
-1% -$2.6K 0.04% 337
2016
Q2 		$239K Buy
+7,176
New +$246K 0.03% 352

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Gerstein Fisher's EW Position: Q3 2016 in Review

Gerstein Fisher reduced its Edwards Lifesciences (EW) stake by 0.96% in Q3 2016, selling an estimated $2.6K and leaving 7,107 shares worth $286K. The position accounts for 0.04% of the portfolio, ranked #337.

Gerstein Fisher first reported a position in EW in Q2 2016 and has held it in 2 quarters since. 694 funds tracked by Wall St. Rank hold EW as of Q3 2016.

  • Gerstein Fisher held 7,107 shares of Edwards Lifesciences worth $286K as of Q3 2016.
  • Gerstein Fisher sold 69 Edwards Lifesciences shares in Q3 2016, an estimated $2.6K.
  • Edwards Lifesciences made up 0.04% of Gerstein Fisher's portfolio in Q3 2016, its #337 holding.
  • Gerstein Fisher first reported a position in Edwards Lifesciences in Q2 2016 and has held it in 2 quarters since.
  • 694 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2016.

Based on Gerstein Fisher's 13F filing for Q3 2016, filed 15 Nov 2016.